These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12784186)

  • 1. The association between end-stage diabetic nephropathy and methylenetetrahydrofolate reductase genotype with macroangiopathy in type 2 diabetes mellitus.
    Hasegawa G; Obayashi H; Kamiuchi K; Nakai M; Kanatsuna T; Yamaguchi M; Tanaka T; Shigeta H; Fujii M; Yoshikawa T; Nakamura N
    Exp Clin Endocrinol Diabetes; 2003 May; 111(3):132-8. PubMed ID: 12784186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus.
    Ksiazek P; Bednarek-Skublewska A; Buraczyńska M
    Med Sci Monit; 2004 Feb; 10(2):BR47-51. PubMed ID: 14737040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of the methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy.
    Eroglu Z; Erdogan M; Tetik A; Karadeniz M; Cetinalp S; Kosova B; Gunduz C; Ozgen AG; Yilmaz C
    Diabetes Metab Res Rev; 2007 Nov; 23(8):621-4. PubMed ID: 17354258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients.
    Mtiraoui N; Ezzidi I; Chaieb M; Marmouche H; Aouni Z; Chaieb A; Mahjoub T; Vaxillaire M; Almawi WY
    Diabetes Res Clin Pract; 2007 Jan; 75(1):99-106. PubMed ID: 16828193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy.
    Böger CA; Stubanus M; Haak T; Götz AK; Christ J; Hoffmann U; Riegger GA; Krämer BK
    Nephrol Dial Transplant; 2007 Jan; 22(1):154-62. PubMed ID: 17005529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study.
    Russo GT; Di Benedetto A; Magazzù D; Giandalia A; Giorda CB; Ientile R; Previti M; Di Cesare E; Cucinotta D
    Acta Diabetol; 2011 Jun; 48(2):95-101. PubMed ID: 19937354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes.
    Hermans MP; Gala JL; Buysschaert M
    Diabet Med; 2006 May; 23(5):529-36. PubMed ID: 16681562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermolabile methylenetetrahydrofolate reductase enzyme genotype is frequent in type 2 diabetic patients with normal fasting homocysteine levels.
    Tutuncu NB; Erbas T; Alikasifoglu M; Tuncbilek E
    J Intern Med; 2005 May; 257(5):446-53. PubMed ID: 15836661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The relationship of methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in type 2 diabetes mellitus patients with diabetic retinopathy].
    Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):131-4. PubMed ID: 12673582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylenetetrahydrofolate reductase gene polymorphism, homocysteine and risk of macroangiopathy in Type 2 diabetes mellitus.
    Sun J; Xu Y; Zhu Y; Lu H
    J Endocrinol Invest; 2006 Oct; 29(9):814-20. PubMed ID: 17114913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylenetetrahydrofolate reductase gene polymorphisms in essential hypertension relation: with the development of hypertensive end-stage renal disease.
    Tylicki L; Födinger M; Puttinger H; Rutkowski P; Strozecki P; Tyszko S; Rutkowski B; Hörl WH
    Am J Hypertens; 2005 Nov; 18(11):1442-8. PubMed ID: 16280279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.
    Maeda M; Yamamoto I; Fukuda M; Motomura T; Nishida M; Nonen S; Fujio Y; Kasayama S; Azuma J
    J Diabetes Complications; 2008; 22(2):119-25. PubMed ID: 18280442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylenetetrahydrofolate reductase polymorphism 677C>T is associated with peripheral arterial disease in type 2 diabetes.
    Pollex RL; Mamakeesick M; Zinman B; Harris SB; Hanley AJ; Hegele RA
    Cardiovasc Diabetol; 2005 Nov; 4():17. PubMed ID: 16274479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
    Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A
    Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the DD genotype and development of Japanese type 2 diabetic nephropathy.
    Gohda T; Makita Y; Shike T; Kobayashi M; Funabiki K; Haneda M; Kikkawa R; Watanabe T; Baba T; Yoshida H; Tomino Y
    Clin Nephrol; 2001 Dec; 56(6):475-80. PubMed ID: 11770799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylenetetrahydrofolate reductase polymorphism, type II diabetes mellitus, coronary artery disease, and essential hypertension in the Czech population.
    Benes P; Kanková K; Muzík J; Groch L; Benedík J; Elbl L; Izakovicová-Hollá L; Vasků A; Znojil V; Vácha J
    Mol Genet Metab; 2001 Jun; 73(2):188-95. PubMed ID: 11386855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total plasma homocysteine is associated with hypertension in Type I diabetic patients.
    Neugebauer S; Tarnow L; Stehouwer C; Teerlink T; Baba T; Watanabe T; Parving HH
    Diabetologia; 2002 Sep; 45(9):1315-24. PubMed ID: 12242465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes].
    Fanelli A; Hadjadj S; Gallois Y; Fumeron F; Betoule D; Grandchamp B; Marre M
    Arch Mal Coeur Vaiss; 2002; 95(7-8):701-8. PubMed ID: 12365083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced serum homocysteine levels in type 2 diabetes.
    Mazza A; Bossone E; Mazza F; Distante A
    Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):118-24. PubMed ID: 15871860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between MTHFR gene polymorphisms, plasma homocysteine levels and diabetic retinopathy in type 2 diabetes mellitus.
    Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y
    Chin Med J (Engl); 2003 Jan; 116(1):145-7. PubMed ID: 12667409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.